NAPWA

ASHM's inaugural Clinical Lecture Series 'Treatment as Prevention?' held in Sydney, Brisbane and Melbourne late March was hailed a success. The keynote presentation was delivered by international speaker Dr Kenneth Mayer, M.D. Professor of Medicine at Harvard, and Director of Research at the Fenway Institute and the Beth Israel Deaconess Medical Center. Video from the talk is now available.

ASHM's inaugural Clinical Lecture Series 'Treatment as Prevention?' held in Sydney, Brisbane and Melbourne late March was hailed a success. The keynote presentation was delivered by international speaker Dr Kenneth Mayer, M.D. Professor of Medicine at Harvard, and Director of Research at the Fenway Institute and the Beth Israel Deaconess Medical Center. Video is now available from the talk.

Two papers in The New England Journal of Medicine, one co-authored by ASHM President Edwina Wright and the other co-authored by board member David Cooper and ASHM member Anthony Kelleher - suggest that starting antiretroviral treatment (ART) early after HIV infection is diagnosed may improve patients' immune response, boosting the initial recovery of the immune system and delaying progression of the disease. A/Prof Edwina Wright and A/Prof Anthony Kelleher provided reviews about their respective research.

There has been an outbreak of invasive meningococcal disease (IMD) amongst MSM in New York City and Brooklyn. A total of 22 cases have been reported, 1 in 2010, 4 in 2011, 13 in 2012 and 4 in 2013. The age range of these patients is between 21-59 years. Read ASHM's advice for medical practitioners regarding vaccination advice, as well as information from Department of Health, Victoria for MSM travelling to New York, and a press release from AFAO.

There has been an outbreak of invasive meningococcal disease (IMD) amongst MSM in New York City and Brooklyn. A total of 22 cases have been reported, 1 in 2010, 4 in 2011, 13 in 2012 and 4 in 2013. The age range of these patients is between 21-59 years. Read ASHM's advice for medical practitioners regarding vaccination advice, as well as information from Department of Health, Victoria for MSM travelling to New York.

There has been an outbreak of invasive meningococcal disease (IMD) amongst MSM in New York City and Brooklyn. A total of 22 cases have been reported, 1 in 2010, 4 in 2011, 13 in 2012 and 4 in 2013. The age range of these patients is between 21-59 years.

The draft National Guidelines for Post-Exposure Prophylaxis after Non-Occupational and Occupational Exposure to HIV are now available for public consultation and feedback. ASHM invites your feedback on these documents. The public consultation period will end on Monday, 25 March 2013 - you can submit your views via a template questionnaire.

The Australasian Society for HIV Medicine (ASHM) welcomes the announcement that two new hepatitis C treatment drugs - boceprevir and telaprevir - will be listed on the Pharmaceutical Benefits Scheme (PBS). Read ASHM's media release.

In light of new HIV research published about attitudes to Treatment as Prevention, ASHM is renewing calls for the PBAC to review its criteria so that doctors are free to decide when to initiate antiretroviral therapy with their patients on a case by case basis. Read ASHM's press release about Treatment as Prevention.

On the 8th of February, NSW Health Minister Jillian Skinner launched Ending HIV: a ground-breaking education initiative designed to help end the HIV epidemic in NSW, timed to coincide with the start of this year's historic 35th Sydney Mardi Gras festival.

ASHM is seeking a highly skilled, experienced and professional individual with solid management experience to fill the role of National Policy & Education Division Manager. Application deadline: 10am Wednesday 20th February 2013.

ASHM is seeking nominations from clinicians and scientists with expertise and experience in HIV management to join its newly formed Board Sub-Committee for the Provision of Clinical Advice on HIV Management. Deadline for applications is COB 12 February 2013.

ASHM is seeking nominations from clinicians and scientists with expertise and experience in HIV management to join its newly formed Board Sub-Committee for the Provision of Clinical Advice on HIV Management.